通化东宝 (600867)

Tonghua Dongbao Pharmaceutical Co., Ltd.

ASH

Tags

MSCI Component StocksQFII Heavy PositionsSpecial Purpose LoansWeight Loss DrugsInnovative DrugsPharmaceutical ManufacturingPharmaceuticals and HealthcareSynthetic BiologyBuyback PlansGene ConceptSmart HealthcareBiological ProductsHigh-Performing StocksShareholder IncreaseMargin Trading and Securities Lending医药生物

K-Line Chart

No K-line data available

Company NameTonghua Dongbao Pharmaceutical Co., Ltd.
Listing Date1994-08-24
Issue Price6.5RMB
Registered Capital195854.282910k RMB
Legal RepresentativeLi Jiahong
Registered AddressDongbao New Village, Tonghua County, Jilin Province
IndustryBiological Products
Main BusinessHard capsules, tablets (including hormone preparations), granules, small-volume injections, active pharmaceutical ingredients (recombinant human insulin), bioengineering products (recombinant human insulin injections), Class II 6854 operating room, emergency room, diagnostic and therapeutic equipment and instruments, Class II 6815 injection and puncture instruments, Class III 6815 injection and puncture instruments, 240 blood glucose meters, 241 blood collection needles, 315 injection and puncture instruments.
Company ProfileTonghua Dongbao Pharmaceutical was founded in 1985 and is one of the earliest listed pharmaceutical companies on the Shanghai Stock Exchange in China, with a current total market capitalization of 40 billion RMB. Since the 1990s, it has been committed to the research, development, and production of high-end biological drugs. It has now become a leading enterprise in China's recombinant biological drug sector, especially in the field of recombinant human insulin production. It has branches in Germany, Switzerland, Malaysia, and in Changchun, Beijing, Shanghai, and Xiamen in China.

Stock Details

1. Key Indicators

  • Total Shares(W): 195854.28
  • Circulating A-Shares(W): 195854.28
  • Earnings Per Share(RMB): 0.6100
  • Net Assets Per Share(RMB): 3.6397
  • Operating Revenue(W RMB): 217958.85
  • Total Profit(W RMB): 144056.38
  • **Net Profit Attributable to Parent(W RMB) **: 120223.44
  • Net Profit Growth Rate(%): 1911.35
  • Weighted Return on Equity(%): 17.7700
  • Operating Cash Flow Per Share(RMB): 0.1940
  • Undistributed Profit Per Share(RMB): 1.9804
  • Capital Reserve Per Share(RMB): 0.1549

2. Main Business

The main business covers:

  • Pharmaceutical R&D and Manufacturing

3. Company Basic Information

  • Company Name: Tonghua Dongbao Pharmaceutical Co., Ltd.
  • Listing Date: 1994-08-24
  • Industry: Pharmaceutical Manufacturing
  • Address: Dongbao New Village, Tonghua County, Jilin Province
  • Website: http://www.thdb.com
  • Company Profile: The company's predecessor was Tonghua Changbai Mountain Pharmaceutical Factory. It began restructuring into a joint-stock company in December 1992, converting the original company's net assets and other sponsors' investments into 43.2 million sponsor legal person shares and privately placing 10.8 million employee shares. After the initial public offering in June of the following year, the total number of shares at the time of listing was 72 million shares; 13.5 million internal employee shares were listed for trading on April 26, 1996.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Dongbao Industrial Group Co., Ltd. General Legal Person 61382.35 31.34
2 Tianjin Zhenyi Equity Investment Partnership (Limited Partnership) General Legal Person 18305.90 9.35
3 Hong Kong Securities Clearing Company Ltd. Northbound Funds 3584.43 1.83
4 Abu Dhabi Investment Authority QFII 3296.05 1.68
5 China Merchants Guozheng Biomedical Index Securities Investment Fund (LOF) Class A Fund 1722.45 0.88
6 CSI 500 Exchange Traded Open End Index Securities Investment Fund Fund 1705.39 0.87
7 Yinhua CSI Innovative Pharmaceutical Industry Exchange Traded Open End Index Securities Investment Fund Fund 1155.82 0.59
8 Tonghua Dongbao Pharmaceutical Co., Ltd. - 2025 Employee Stock Ownership Plan Asset Management Plan 929.00 0.47
9 Tonghua Jixiang Chuangying Investment Management Center General Legal Person 731.82 0.37
10 BOCA CSI 500 Index Enhanced Securities Investment Fund Class A Fund 5.02 0.00

5. Concept Sectors

  • Gene Concept
  • Intelligent Healthcare
  • Innovative Drugs
  • Weight Loss Drugs
  • Synthetic Biology
  • Margin Trading & Securities Lending
  • QFII Heavy Holdings
  • Shareholder Increase
  • Share Repurchase Plan
  • Recent Highs
  • MSCI Constituent
  • Special Loans

Remarks

  • Data update date: 2025-09-30
  • Data source: Public Market Information